Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration

Published:2014-11 Issue:11 Volume:121 Page:2181-2192
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Ho Allen C.,Busbee Brandon G.,Regillo Carl D.,Wieland Mark R.,Van Everen Sherri A.,Li Zhengrong,Rubio Roman G.,Lai Phillip

Publisher

Elsevier BV

Subject

Ophthalmology

Reference26 articles.

1. Vision Health Cost-Effectiveness Study Group. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments;Rein;Arch Ophthalmol,2009

2. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis;Wong;Ophthalmology,2008

3. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes;Lopez;Invest Ophthalmol Vis Sci,1996

4. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

5. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study;Brown;Ophthalmology,2009

Cited by 272 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bispecific Vascular Endothelial Growth Factor-A and Angiopoietin-2 Antagonist RO-101 Preclinical Efficacy in Model of Neovascular Eye Disease;Ophthalmology Science;2024-01

2. Machine Learning to Predict Response to Ranibizumab in Neovascular Age-Related Macular Degeneration;Ophthalmology Science;2023-12

3. The Localization of Intraretinal Cysts Has a Clinical Role on the 2-Year Outcome of Neovascular Age-Related Macular Degeneration;Ophthalmology Retina;2023-12

4. Retinal pigment epithelium elevation values as a marker in determining the anatomical prognosis and treatment regimen of type 2 macular neovascularization;2023-11-06

5. Ranibizumab for the treatment of Age-Related Macular Degeneration related research hotspot and dynamic;2023-10-18